Case Information
*1 Filed 9/30/16
CERTIFIED FOR PUBLICATION
IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA FIRST APPELLATE DISTRICT DIVISION FOUR
THE PEOPLE, Plaintiff and Respondent, A142424 v. (Contra Costa County
LATANYA A. STAMPS, Super. Ct. No. 51315373) Defendant and Appellant.
Appellant Latanya A. Stamps was convicted of multiple drug possession offenses after drugs in both pill and crystalline form were discovered in her car, purse or clothing on four different dates in October through December 2012. She appeals, arguing the court improperly admitted the testimony of an expert criminalist who identified the drugs in pill form as controlled substances solely by comparing their appearance to pills pictured on a Web site called “Ident-A-Drug.” Stamps attacks her convictions for possession of oxycodone and dihydrocodeinone on grounds that (1) the expert’s testimony was based on unreliable and inadmissible hearsay from the Web site and did not involve the use of the witness’s expertise; and (2) there was insufficient evidence to convict on the counts involving those drugs because the expert relied exclusively on the Web site in rendering her opinion. Because we agree that the expert testimony was improperly admitted, and because the testimony was central to Stamps’s pill-based convictions, we reverse Stamps’s convictions on counts one, five, seven and eight. [1] We *2 conclude, however, that a retrial on those counts is not barred by double jeopardy principles.
I. BACKGROUND
On four occasions in October through December 2012, Stamps was pulled over by the Pittsburg police because her car did not display a license plate. On each occasion she and her car were searched, and on each occasion drugs were discovered. On October 30, 2012, the police discovered two yellow oval tablets with a capital “V” on one side and a white oval tablet with the word “Watson” on its side. The next night, the police again stopped Stamps’s car, conducted a search, and discovered a methamphetamine pipe and 1.19 grams of a white crystalline substance believed to be methamphetamine. Yet again, on November 1, 2012, they found a bindle of white crystalline substance believed to be methamphetamine, weighing .25 gram, six white oblong pills, one with the words “Watson” and “853” printed on it, and .28 gram of some white chunky substance believed to be cocaine base. On December 16, they found .03 gram of suspected methamphetamine in a plastic baggie in Stamps’s bra and two pills in her car. One of the pills was yellow with “853” written on it, and the other was a white tablet bearing the words “Watson 932.”
Stamps was charged with eight counts of drug possession: three counts of possession of methamphetamine (Health & Saf. Code, § 11377, subd. (a)), one count of possession of cocaine (Health & Saf. Code,§§ 11350, subd. (a), 11379, subd. (a)), one count of possession of oxycodone (Health & Saf. Code, § 11350, subd. (a)), and three counts of possession of dihydrocodeinone (Health & Saf. Code, § 11350, subd. (a)). At trial, the People proved the chemical composition of the crystalline and chunky substances through the testimony of criminalist Shana Meldrum, an employee of the Contra Costa County Sheriff’s Crime Lab. Meldrum performed a detailed chemical analysis on the suspected methamphetamine and cocaine, and her tests confirmed the drugs were as suspected. With respect to the drugs in pill form, however, Meldrum identified the pills as oxycodone and dihydrocodeinone based solely on a visual comparison of the seized pills to those displayed on the Ident-A-Drug Web site. Based *3 on the shape and color of the pills, their markings and their condition, Meldrum concluded they contained the alleged substances. This visual comparison was considered a “presumptive test” of each pill’s chemical composition. Meldrum did no confirming chemical analysis of the pills. In addition to the expert’s testimony, Stamps had given statements to the police on the dates of her arrests indicating the pills found on October 30, 2012, were Norco and Phexoreal, and the pills found on November 1, 2012 were “Norcos.”
The jury found Stamps guilty on all eight counts, and she was placed on probation for two years. On appeal she challenges her convictions only on the four counts stemming from her possession of the various pills described above.
II. DISCUSSION
A. Admissibility of the Ident-A-Drug Evidence
Stamps contends Meldrum should not have been allowed to testify to the contents
of the Ident-A-Drug Web site because the testimony brought before the jury inadmissible
and unreliable hearsay which the jurors may have used as direct evidence of the charged
offenses. She further argues the expert’s testimony should have been excluded because
matching the pills to a photograph on a Web site did not involve the use of the witness’s
expertise.
[2]
(See
State v. Ward
(N.C. 2010)
1. The Issue Was Not Forfeited Preliminarily, we reject the People’s contention that Stamps’s argument was forfeited by failure to object in the trial court on the specific ground that too much detail was provided by the expert about the Web site or that reliability of the Web site had not been established. Stamps’s counsel did object repeatedly on grounds of hearsay and lack of foundation, which adequately alerted the court to the basis of objection and were sufficient to preserve the issue for review. (See People v. Carillo (2004) 119 Cal.App.4th 94, 101 [issue is whether the objection “ ‘fairly apprises the trial court of the issue it is being called upon to decide’ ”].)
2.
Expert Reliance on Hearsay Under California Law
Until very recently, the law governing expert witnesses’ reliance on hearsay—and
the latitude given them to testify about such hearsay—seemed fairly well settled. For
instance, in
People v. Gardeley
(1996)
But even in holding such hearsay admissible,
Gardeley
and similar cases placed
some limits on its admissibility by cautioning that “any material that forms the basis of an
expert’s opinion testimony must be reliable. [Citation.] For ‘the law does not accord to
the expert’s opinion the same degree of credence or integrity as it does the data
underlying the opinion. Like a house built on sand, the expert’s opinion is no better than
the facts on which it is based.’ ” (
Gardeley
,
Recently, however, the not-admitted-for-its-truth rationale was jettisoned
altogether—at least with respect to “case-specific hearsay”—when a unanimous Supreme
Court announced: “this paradigm is no longer tenable because an expert’s testimony
regarding the basis for an opinion
must
be considered for its truth by the jury.” (
People v.
Sanchez
(2016)
Sanchez
dealt with a gang expert’s testimony subject to a challenge under
Crawford v. Washington
(2004)
Incorporated within the Sanchez rule is what appears to be a new litmus test for admissibility of expert testimony incorporating hearsay as the basis for the expert’s opinion: it depends on whether the matter the prosecution seeks to elicit is “case-specific hearsay” or, instead, part of the “general background information” acquired by the expert through out-of-court statements as part of the development of his or her expertise. ( Sanchez , supra , 63 Cal.4th at p. 678.) Though most jurists may find this a novel approach, the Supreme Court took pains to explain that the rule announced in Sanchez in fact “restores the traditional distinction between an expert’s testimony regarding background information and case-specific facts” that had existed at common law and in the early California cases. ( Id . at p. 685.) Sanchez itself acknowledged that the line between “case-specific facts” and “general background information” had “become blurred” due to decades of statutory and case law that paid no heed to such a distinction. ( Id . at p. 678.)
After Sanchez , reliability is no longer the sole touchstone of admissibility where expert testimony to hearsay is at issue. Admissibility—at least where “case-specific hearsay” is concerned—is now more cut-and-dried: If it is a case-specific fact and the witness has no personal knowledge of it, if no hearsay exception applies, and if the expert treats the fact as true, the expert simply may not testify about it. ( , 63 Cal.4th at pp. 684–686.) The underlying fact also may not be included in a hypothetical *8 question posed to the expert unless it has been proven by independent admissible evidence. ( Id. at pp. 684, 686.) If the hearsay relied upon by the expert is not case- specific, as we read Sanchez , the evidence still is admitted for its truth ( id . at pp. 685– 686), and is therefore hearsay, but we tolerate its admission due to the latitude we accord experts, as a matter of practicality, in explaining the basis for their opinions ( id . at p. 676). Where general background hearsay is concerned, the expert may testify about it so long as it is reliable and of a type generally relied upon by experts in the field, again subject to the court’s gatekeeping duty under Sargon . ( , at pp. 676–679, 685; Evid. Code, §§ 801, 802.)
3. The Ident-A-Drug Testimony Was Inadmissible Because It Was Case- Specific
Stamps argues, and the People do not contest, that the content of the Ident-A-Drug
Web site would not be independently admissible to prove its truth because it was
hearsay.
[6]
(Evid. Code, § 1200, subd. (a);
People v. Franzen
(2012) 210 Cal.App.4th
1193, 1203–1215 [police use of Web site containing cell phone data did not make
information retrieved from the Web site admissible over a hearsay objection];
People v.
Hard
(Colo. Ct. App. 2014)
The Attorney General has proposed no hearsay exception that would render the
Ident-A-Drug Web site contents admissible. Because the Ident-A-Drug content was itself
inadmissible hearsay, and because that content was case-specific, Meldrum’s testimony
about the Web site was inadmissible under the new paradigm. defined “case-
specific” facts as those “relating to the particular events and participants alleged to have
been involved in the case being tried.” (
4.
Harmless Error Analysis
We review the erroneous admission of expert testimony under the state standard of
prejudice. (
People v. Watson
(1956)
First,
Sanchez
specifically held a limiting instruction was not effective in
preventing the jury from considering the hearsay as direct evidence of the facts asserted.
( ,
Because the Ident-A-Drug testimony was the only evidence that the pills actually
contained the controlled substances alleged in the information, the convictions on counts
one, five, seven and eight must be reversed. In this case, unlike some others, there was
no chemical analysis to supplement the expert’s testimony based on visual similarities
she noted on Ident-A-Drug (cf.
State v. Stank
(Wis. App. 2005)
There were, of course, admissions by Stamps that some of the pills were Norco and Phexoreal, but there was no testimony that these brand names are equivalent to oxycodone and dihydrocodeinone. And though this evidence may prove Stamps believed she was in possession of controlled substances, Meldrum’s testimony was the only evidence that the pills actually contained dihydrocodeinone and oxycodone, as charged. We conclude it is reasonably probable the jury would have acquitted Stamps of the charges based on pill possession in the absence of the Ident-A-Drug testimony.
The evidence in question, consisting solely of Meldrum’s unfiltered and unvarnished recapitulation of what she saw on the Ident-A-Drug Web site, was case- specific, did not come within any hearsay exception, was not personally known to the witness as a fact, was treated as true by Meldrum, and was inadmissible under . Because it was central to conviction on the counts involving pills, we must reverse as to those counts.
B. Sufficiency of the Evidence
Although reversal is required based on inadmissibility of the evidence alone, we
consider Stamps’s insufficiency of the evidence argument as well, in order to determine
whether retrial is barred by double jeopardy principles, as announced in
Burks v. United
States
(1978)
III. DISPOSITION
The judgment is reversed as to counts one, five, seven and eight. In all other respects it is affirmed. The cause is remanded to the superior court for further proceedings not inconsistent with this opinion.
_________________________ Streeter, J.
We concur:
_________________________
Reardon, Acting P.J.
_________________________
Rivera, J.
A142424/ People v. Stamps
People v. Stamps (A142424)
Trial Court: Contra Costa County Superior Court
Trial Judge: Hon. John C. Cope
Counsel:
Alfons Wagner, J. Bradley O’Connell, under appointment by the Court of Appeal, for Defendant and Appellant.
Kamala D. Harris, Attorney General, Gerald A. Engler, Chief Assistant Attorney General, Jeffrey M. Laurence, Senior Assistant Attorney General, Catherine A. Rivlin, Supervising Deputy Attorney General, Ann P. Wathen, Deputy Attorney General for Plaintiff and Respondent.
Notes
[1] Stamps’s briefs identify the challenged counts as one, three, seven and eight, but it appears the correct counts are one, five, seven and eight.
[2] Nor did Meldrum testify that any special expertise was required to use the Ident-
A-Drug Web site. She testified she “entered the markings on the pill into the website and
obtained a match result to the markings, to the shape and to the color of the pills, and
presumptively identified those” as oxycodone and dihydrocodeinone. Her testimony did
not reveal any special expertise required to interpret the results provided by Ident-A-Drug
beyond ordinary visual acuity, and she added nothing of her expertise to the Ident-A-
Drug information so as to make it an integral part of some larger opinion. By admitting
Meldrum’s testimony that the contents of the Ident-A-Drug Web site “match[ed]” the pill
found in Stamps’s possession, the court allowed her to place case-specific non-expert
opinion before the jury, with the near certainty that the jury would rely on the underlying
hearsay as direct proof of the chemical composition of the pills. The conclusion is
unavoidable that Meldrum was a “mere conduit” for the Ident-A-Drug hearsay. (
I-CA
Enterprises, Inc. v. Palram Americas, Inc.
(2015)
[3] Specifically, Sargon requires trial courts to probe expert testimony under Evidence Code sections 801, subdivision (b), and 802 and exclude any portion of it “that is (1) based on matter of a type on which an expert may not reasonably rely, (2) based on reasons unsupported by the material on which the expert relies, or (3) speculative. Other provisions of law, including decisional law, may also provide reasons for excluding expert opinion testimony.” ( Sargon , 55 Cal.4th at pp. 771–772.)
[4]
Sanchez
specifically disapproved several of the Supreme Court’s earlier cases to
the extent they conflicted with its holding, including
Gardeley
,
supra
,
[5] The Crawford line of cases has no direct application here because the challenged hearsay was not testimonial. (See Crawford , 541 U.S. at pp. 50–53.)
[6] Based on Meldrum’s testimony, it appears the Web site provided photographs of pills, together with sufficient text to communicate that the photograph depicted a specified pharmaceutical. This combined content would constitute an out-of-court “statement” of a “person” (the person who entered the information on the Web site) so as to bring it within the definition of hearsay. (Evid. Code, §§ 225, 1200, subd. (a).)
